What does Eton Pharmaceuticals, Inc. do?
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical…
What is Eton Pharmaceuticals, Inc.'s P/E and P/B ratio?
Eton Pharmaceuticals, Inc. has a P/E ratio of 125.0 and a P/B ratio of 30.69.
What is Eton Pharmaceuticals, Inc.'s debt-to-equity ratio?
Eton Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.63.
How much does Eton Pharmaceuticals, Inc. owe compared with what it owns?
Eton Pharmaceuticals, Inc. owes $0.60 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Eton Pharmaceuticals, Inc.'s Positivity rank?
Eton Pharmaceuticals, Inc. is ranked #6,162 of 6,775 companies globally and #3,502 of 4,000 in United States on PositoAI, with a Positivity Score of 6,330.
Does Eton Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Eton Pharmaceuticals, Inc..
Where can I read the latest news about Eton Pharmaceuticals, Inc.?
Recent headlines about Eton Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Eton Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Eton Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.